Center for Health Promotion and Prevention Research, The University of Texas School of Public Health, 7000 Fannin Street, Houston, TX 77030, USA.
J Cancer Surviv. 2013 Sep;7(3):464-83. doi: 10.1007/s11764-013-0290-x. Epub 2013 May 16.
Regular surveillance decreases the risk of recurrent cancer in colorectal cancer (CRC) survivors. However, studies suggest that receipt of follow-up tests is not consistent with guidelines. This systematic review aimed to: (1) examine receipt of recommended post-treatment surveillance tests and procedures among CRC survivors, including adherence to established guidelines, and (2) identify correlates of CRC surveillance.
Systematic searches of Medline, PubMed, PsycINFO, CINAHL Plus, and Scopus databases were conducted using terms adapted for each database's keywords and subject headings. Studies were screened for inclusion using a three-step process: (1) lead author reviewed abstracts of all eligible studies; (2) coauthors reviewed random 5 % samples of abstracts; and (3) two sets of coauthors reviewed all "maybe" abstracts. Discrepancies were adjudicated through discussion.
Thirty-four studies are included in the review. Overall adherence ranged from 12 to 87 %. Within the initial 12 to 18 months post-treatment, adherence to recommended office visits was 93 %. Adherence ranged from 78 to 98 % for physical exams, 18-61 % for colonoscopy, and 17-71 % for carcinoembryonic antigen (CEA) testing. By 2 to 3 years post-treatment, cumulative adherence ranged from 70 to 88 % for office visits, 89-93 % for physical exams, 49-94 % for colonoscopy, and 7-79 % for CEA testing. Between 18 and 28 % of CRC survivors received greater than recommended overall surveillance; overuse of physical exams (42 %), colonoscopy (24-76 %), and metastatic disease testing (1-29 %) was also prevalent. Studies of correlates of CRC surveillance focused on sociodemographic and disease/treatment characteristics, and patterns of association were inconsistent across studies.
Deviation from surveillance recommendations includes both under- and overuse. Examination of modifiable determinants is needed to inform interventions targeting appropriate and timely receipt of recommended surveillance.
Among CRC survivors, it remains unclear what modifiable psychosocial factors are associated with the observed under- and overuse of surveillance. Understanding and intervening with these psychosocial factors is critical to improving adherence to guideline-recommended surveillance and thereby reducing mortality among this group of survivors.
定期监测可降低结直肠癌(CRC)幸存者癌症复发的风险。然而,研究表明,后续检测的接受情况并不符合指南。本系统评价旨在:(1)检查 CRC 幸存者接受推荐的治疗后监测测试和程序的情况,包括是否符合既定指南;(2)确定 CRC 监测的相关因素。
使用针对每个数据库的关键字和主题词改编的术语,对 Medline、PubMed、PsycINFO、CINAHL Plus 和 Scopus 数据库进行系统检索。使用三步法筛选研究是否纳入:(1)主要作者审查所有合格研究的摘要;(2)共同作者审查摘要的随机 5%样本;(3)两组共同作者审查所有“可能”的摘要。通过讨论解决分歧。
本综述纳入了 34 项研究。总体依从率为 12%至 87%。在治疗后最初的 12 至 18 个月内,对推荐的就诊的依从率为 93%。体格检查的依从率为 78%至 98%,结肠镜检查为 18%至 61%,癌胚抗原(CEA)检测为 17%至 71%。在治疗后 2 至 3 年,就诊的累积依从率为 70%至 88%,体格检查为 89%至 93%,结肠镜检查为 49%至 94%,CEA 检测为 7%至 79%。18%至 28%的 CRC 幸存者接受了超过推荐的整体监测;过度使用体格检查(42%)、结肠镜检查(24%至 76%)和转移性疾病检测(1%至 29%)也很常见。CRC 监测相关因素的研究侧重于社会人口学和疾病/治疗特征,研究之间的关联模式不一致。
对监测建议的偏离包括不足和过度使用。需要检查可改变的决定因素,为针对适当和及时接受推荐的监测的干预措施提供信息。
在 CRC 幸存者中,仍不清楚哪些可改变的心理社会因素与观察到的监测不足和过度使用有关。了解和干预这些心理社会因素对于提高对指南推荐的监测的依从性从而降低该组幸存者的死亡率至关重要。